DISCOVERY AND DEVELOPMENT SERVICES
AMRI combines broad target class coverage and access to state-of-the-art technology with
expertise in multiple disease areas to offer a complete drug discovery portfolio of services.
Through discovery biology, synthetic and medicinal chemistry, ADMET and bioanalytical
offerings, AMRI supports hit identification programs through candidate selection. In addition,
services to support preclinical and clinical progression including chemical process R&D,
pre-formulation and formulation development, analytical development, material sciences,
separations sciences, solid state chemistry, GMP manufacturing and container closure
testing are a hallmark of AMRI.
AMRI supports the chemical development and cGMP manufacture of more than
200 custom and complex active pharmaceutical ingredients (APIs). Our technology
expertise includes hydrogenation, fermentation, photocatalytic chemistry, bio
transformation, industrial chromatography, flow chemistry and spray drying.
DRUG PRODUCT MANUFACTURING (DPM)
We support development through commercial-scale production of complex liquid-filled
and lyophilized parenterals, sterile suspensions and ophthalmic formulations. AMRI offers
flexibility in final dosage form and advanced fill-technology.
Backed by 25 years of experience, AMRI delivers high-quality solutions for your complex projects.
Visit our website to learn more: amriglobal.com
AMRI • 26 Corporate Circle • Albany, NY 12203
General Inquiries: 518-512-2000 • Investor Inquiries: 518-512-2261
AMRI offers a complete suite of capabilities across the drug
discovery, development and manufacturing spectrum.
Our key business segments include: